The British Medical Journal released the study’s findings, which showed that some anticholinergics were not associated with a higher risk of dementia.
These included trospium chloride, propiverine hydrochloride, flavoxate hydrochloride, darifenacin, and fesoterodine fumarate.
Mirabegron, a non-anticholinergic medication that is likewise provided to individuals with overactive bladders but functions via a different mechanism than anticholinergics, was also examined by the experts.
Although the researchers did discover some evidence linking this medication to dementia, they pointed out that the data was unclear and that further investigation is required.
Clinicians should “consider the possible long term risks and consequences of the available treatment options for an overactive bladder in older adults,” the authors said in their paper.
‘Consider prescribing alternate medications that could be linked with a decreased risk of dementia,’ they advised.
